K. Peony Yu

2018

In 2018, K. Peony Yu earned a total compensation of $4.5M as Chief Medical Officer at FibroGen, a 44% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$371,394
Option Awards$1,857,818
Salary$564,000
Stock Awards$1,720,000
Other$19,152
Total$4,532,364

Yu received $1.9M in option awards, accounting for 41% of the total pay in 2018.

Yu also received $371.4K in non-equity incentive plan, $564K in salary, $1.7M in stock awards and $19.2K in other compensation.

Rankings

In 2018, K. Peony Yu's compensation ranked 2,324th out of 14,244 executives tracked by ExecPay. In other words, Yu earned more than 83.7% of executives.

ClassificationRankingPercentile
All
2,324
out of 14,244
84th
Division
Manufacturing
850
out of 5,765
85th
Major group
Chemicals And Allied Products
285
out of 2,128
87th
Industry group
Drugs
229
out of 1,817
87th
Industry
Pharmaceutical Preparations
178
out of 1,391
87th

Pay ratio

K. Peony Yu's Pay$4,532,364
Median Employee's Pay$212,858
Pay Ratio

21

to 1

In 2018, the annual total compensation of K. Peony Yu was $4,532,364.

The annual total compensation of the median employee at FibroGen was $212,858.

The ratio of K. Peony Yu's pay to the pay of median employee was therefore 21 to one.

Source: SEC filing on April 23, 2019.

Yu's colleagues

We found two more compensation records of executives who worked with K. Peony Yu at FibroGen in 2018.

2018

Thomas Neff

FibroGen

Chief Executive Officer

2018

Pat Cotroneo

FibroGen

Chief Financial Officer

News

You may also like